NASDAQ: ANAC       Arctos Northstar Acquisition Corp Cl A
Last Price Today's Change   Day's Range   Trading Volume
10.19   +0.005 (0.05%)  10.19 - 10.19  705


Avg Volume (4 weeks):705
4 Weeks Range:10.19 - 10.19
4 Weeks Price Volatility (%):
52 Weeks Range:9.76 - 10.19
52 Weeks Price Volatility (%):
Average Price Target: 8.00
Price Target Upside/Downside: -2.19


No recent Headlines for this stock.

Business Background

Anacor Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing small-molecule therapeutics derived from its boron chemistry platform. Its lead product development candidate is crisaborole topical ointment, approximately 2%, a non-steroidal topical anti-inflammatory phosphodiesterase-4 (PDE-4) inhibitor in development for the treatment of mild-to-moderate atopic dermatitis and psoriasis. Its product, KERYDIN (tavaborole) topical solution, approximately 5%, is an oxaborole antifungal approved by the United States Food and Drug Administration (FDA) for the topical treatment of onychomycosis of the toenails. It also has a pipeline of other internally discovered topical and systemic boron-based compounds in early-stages of research and development, which include AN3365. Its compound, AN5568 (SCYX-7158), is licensed to Drugs for Neglected Diseases initiative (DNDi) for the treatment of human African trypanosomiasis.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2869  1585  661  6743 

Top 10 Active Counters
 LYLT 0.2180.00 
 ISBC 13.87-0.35 
 BOXD 0.297+0.117 
 LHDX 0.4520.00 
 SQ 58.87-13.78 
 TCDA 0.1080.00 
 UMPQ 17.660.00 
 TSLA 197.93+6.78 
 FRC 13.862+0.531 
 IAA 39.89-0.04